Status:
UNKNOWN
Dose for Deep Neuromuscular Blockade Deciding Factor of Neuromuscular Blocker Dose for Deep Neuromuscular Blockade
Lead Sponsor:
Seoul National University Bundang Hospital
Conditions:
Laparoscopic Surgery
Eligibility:
All Genders
20-80 years
Brief Summary
Find out the deciding factor(total body weight, corrected body weight, ideal body weight, fat-free mass, body mass index, skeletal muscle mass, body fat) of neuromuscular blocker dose for deep neuromu...
Detailed Description
Before the surgery, total body weight, corrected body weight, ideal body weight, fat-free mass, body mass index were measured by height and weight and skeletal muscle mass and body fat were measured b...
Eligibility Criteria
Inclusion
- patients aged 20-80 and American Society of Anesthesiology Physical Grade (ASA) I-II, who undergo laparoscopic surgery for at least 2 hours under general anesthesia
Exclusion
- kidney disease (GFR\<60)
- allergy to study drugs
- decline participation
- side effect of propofol and remifentanil
- when anesthesia does not maintain the level of alertness (BIS) below 60 even when the anesthetic dose is increased, or when hemodynamic instability such as bradycardia and hypotension appears
Key Trial Info
Start Date :
January 10 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 30 2021
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT04688268
Start Date
January 10 2021
End Date
July 30 2021
Last Update
December 30 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.